Cancellation of state registration. Maxidex®

January 9, 2017

Active substances:

Dexamethasone

Trade names:

Maxidex®

ICD-10:

VII.H00-H06.H01.0 Blepharitis

VII.H10-H13.H10.4 Chronic conjunctivitis

VII.H10-H13.H10.2 Other acute conjunctivitis

VII.H10-H13.H10.1 Acute atopic conjunctivitis

VII.H10-H13.H10.5 Blepharoconjunctivitis

VII.H15-H22.H15.0 Sclerite

VII.H15-H22.H15.1 Episcleritis

VII.H15-H22.H16 Keratite

VII.H15-H22.H16.2 Keratoconjunctivitis

VII.H15-H22.H20.1 Chronic iridocyclitis

VII.H15-H22.H20.0 Acute and subacute iridocyclitis

VII.H43-H45.H44.1 Other endophthalmitis

XIX.S00-S09.S05 Injury of the eye and orbit

Maxidex, dexamethasone, ophthalmic ointment, blepharitis, conjunctivitis, keratitis, eye trauma, treatment of eye diseases

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclude from the state register of medicinal products for medical use of the medicinal product (registration certificate П N013731 / 02 from 09.12.2008 issued Alkon-Kouvreur N.V. S.A., Belgium):

Maxidex® (trade name of the medicinal product)

Dexamethasone (international non-proprietary, or grouping, or chemical name of the drug)

ointment eye, 0.1 % (dosage form, dosage)

ALCON-COUVREUR, n.v. s.a., Belgium (name and address of the location of the manufacturer of the medicinal product)

on the basis of filing by the authorized legal entity LLC Alcon Pharmaceuticals, Russia of a request for the cancellation of the state registration of a medicinal product.